Group One Trading’s Regencell Bioscience RGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-200
Closed -$5.09K – 8340
2026
Q1
$5.09K Hold
200
– – ﹤0.01% 6705
2025
Q4
$4.2K Sell
200
-900
-82% -$14.6K ﹤0.01% 7260
2025
Q3
$17K Buy
+1,100
New +$15.8K ﹤0.01% 6822

Other funds holding RGC

Group One Trading's RGC Position: Q3 2026 in Review

Group One Trading reduced its Regencell Bioscience (RGC) stake by 70% in Q3 2026, selling an estimated $3.88K and leaving 283 shares worth $1.76K. The position accounts for ﹤0.01% of the portfolio, ranked #7015.

Group One Trading first reported a position in RGC in Q3 2025 and has held it in 4 quarters since. The position peaked at $9K in Q1 2026. 31 funds tracked by Wall St. Rank hold RGC as of Q3 2026.

  • Group One Trading held 283 shares of Regencell Bioscience worth $1.76K as of Q3 2026.
  • Group One Trading sold 670 Regencell Bioscience shares in Q3 2026, an estimated $3.88K.
  • Regencell Bioscience made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #7015 holding.
  • Group One Trading first reported a position in Regencell Bioscience in Q3 2025 and has held it in 4 quarters since.
  • Group One Trading's Regencell Bioscience position peaked at $9K in Q1 2026.
  • 31 funds tracked by Wall St. Rank held Regencell Bioscience as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.